Alicia Lozano
Papers
1
Total Citations
3
H-Index
1
About
Alicia Lozano is a clinical researcher whose work centers on optimizing treatment sequencing and outcomes in head and neck oncology, with a particular focus on human papillomavirus (HPV)-associated oropharyngeal squamous cell cancers (OPSCCs). Her major contributions lie in evaluating how the timing of adjuvant therapies—specifically the interval between surgery and radiation therapy—affects patient prognosis in multimodality treatment regimens. In her most-cited study, a multi-institutional cohort analysis, Lozano examined the National Comprehensive Cancer Network (NCCN) guideline recommending a surgery-to-radiation interval of no more than six weeks, providing real-world evidence on adherence and its impact on outcomes in HPV+ disease. This work has garnered early attention with three citations since its 2024 publication, signaling its relevance to ongoing clinical debates. By bridging surgical and radiation oncology perspectives, Lozano’s research helps refine protocols that balance efficacy with patient quality of life. Her findings are particularly valuable for clinicians navigating the complexities of HPV+ OPSCC, where favorable prognosis demands careful treatment de-escalation strategies. Lozano’s collaborative, multi-institutional approach underscores her commitment to evidence-based improvements in cancer care delivery.
Research Focus
Key Achievements
Top Papers
- 1